HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Kikuko Hotta Selected Research
Kikuko Hotta Research Topics
Disease
13
Non-alcoholic Fatty Liver Disease
02/2018 - 06/2008
11
Obesity
08/2021 - 03/2007
5
Fibrosis (Cirrhosis)
02/2024 - 08/2009
4
Insulin Resistance
01/2016 - 03/2010
3
Type 2 Diabetes Mellitus (MODY)
03/2016 - 05/2012
2
Weight Loss (Weight Reduction)
08/2021 - 03/2016
2
Infections
08/2015 - 07/2010
1
Carcinoma (Carcinomatosis)
12/2023
1
Ovarian Neoplasms (Ovarian Cancer)
12/2023
1
Neoplasms (Cancer)
12/2023
1
Cardiovascular Diseases (Cardiovascular Disease)
08/2021
1
Blindness (Hysterical Blindness)
07/2020
1
Vision Disorders (Hemeralopia)
07/2020
1
Leber Congenital Amaurosis
07/2020
1
Mitochondrial Diseases (Mitochondrial Disease)
02/2018
1
Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2016
1
Chronic Hepatitis C
08/2015
1
Body Weight (Weight, Body)
07/2014
1
Hyperglycemia
07/2010
1
Inflammation (Inflammations)
07/2010
1
Hyperferritinemia
03/2010
1
Fibrosarcoma
12/2009
1
Type C Niemann-Pick Disease (Niemann Pick Disease, Type C)
12/2009
1
Alcoholic Fatty Liver
10/2009
1
Neuroblastoma
07/2009
1
Body Weight Changes
07/2009
1
Hypertension (High Blood Pressure)
12/2007
1
Weight Gain
10/2007
1
Edema (Dropsy)
10/2007
1
Fatigue
10/2007
1
Vascular Remodeling
06/2002
Drug/Important Bio-Agent (IBA)
7
Proteins (Proteins, Gene)
FDA Link
02/2024 - 12/2007
6
Glucose (Dextrose)
FDA Link
Generic
03/2016 - 01/2008
5
Triglycerides (Triacylglycerol)
IBA
03/2016 - 01/2008
4
Insulin (Novolin)
FDA Link
01/2016 - 01/2008
4
Adiponectin
IBA
01/2016 - 06/2002
4
Messenger RNA (mRNA)
IBA
08/2015 - 06/2008
4
Alanine Transaminase (SGPT)
IBA
05/2014 - 12/2010
3
Cholesterol
IBA
03/2016 - 01/2008
3
HDL Lipoproteins
IBA
01/2016 - 01/2008
3
HDL Cholesterol
IBA
01/2016 - 01/2008
3
Aspartate Aminotransferases (Aspartate Transaminase)
IBA
05/2014 - 12/2010
3
secretogranin III
IBA
07/2009 - 03/2007
2
Phospholipases (Phospholipase)
IBA
09/2016 - 03/2016
2
DNA (Deoxyribonucleic Acid)
IBA
08/2015 - 05/2014
2
nas
IBA
05/2014 - 07/2013
2
Brain-Derived Neurotrophic Factor (BDNF)
IBA
09/2011 - 12/2009
2
Ferritins (Ferritin)
IBA
12/2010 - 03/2010
2
Type 4 Melanocortin Receptor (Melanocortin-4 Receptor)
IBA
11/2010 - 12/2009
2
Blood Proteins (Serum Proteins)
IBA
07/2010 - 06/2002
2
Hemoglobins (Hemoglobin)
IBA
01/2008 - 01/2008
2
Neuropeptides
IBA
12/2007 - 03/2007
1
Immune Checkpoint Inhibitors
IBA
12/2023
1
moesin
IBA
12/2023
1
Tyrosine (L-Tyrosine)
FDA Link
08/2021
1
Glycolipids
IBA
08/2021
1
Retinaldehyde (Retinal)
IBA
07/2020
1
Oxidoreductases (Dehydrogenase)
IBA
02/2018
1
Collagen Type IV (Type IV Collagen)
IBA
12/2017
1
RNA (Ribonucleic Acid)
IBA
12/2017
1
Hyaluronic Acid (Hyaluronan)
IBA
03/2016
1
alogliptin
IBA
03/2016
1
hydrogen sulfite (bisulfite)
IBA
08/2015
1
Lipids
IBA
07/2014
1
dicarboxydine (DCD)
IBA
05/2012
1
Methionine Sulfoxide Reductases
IBA
11/2010
1
Transcription Factors (Transcription Factor)
IBA
11/2010
1
Immunologic Factors (Immunomodulators)
IBA
07/2010
1
Glycoproteins (Glycoprotein)
IBA
07/2010
1
Orosomucoid (Seromucoid)
IBA
07/2010
1
Acids
IBA
07/2010
1
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
07/2010
1
Adipokines
IBA
07/2010
1
Reactive Oxygen Species (Oxygen Radicals)
IBA
03/2010
1
Elements
IBA
03/2010
1
Biomarkers (Surrogate Marker)
IBA
03/2010
1
Iron
IBA
03/2010
1
Prolactin
IBA
12/2009
1
glucosamine-6-phosphate isomerase
IBA
12/2009
1
Potassium Channels (Potassium Channel)
IBA
12/2009
1
Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)
IBA
10/2009
1
Nitric Oxide (Nitrogen Monoxide)
FDA Link
10/2009
1
Type 1 Angiotensin Receptor
IBA
08/2009
1
Pro-Opiomelanocortin (Proopiomelanocortin)
IBA
07/2009
1
Orexins
IBA
07/2009
1
myotubularin
IBA
02/2009
1
Peroxisome Proliferators
IBA
06/2008
1
Pioglitazone (Actos)
FDA Link
10/2007
1
Transaminases (Aminotransferases)
IBA
10/2007
1
Becaplermin (PDGF-BB)
FDA Link
06/2002
1
Intercellular Signaling Peptides and Proteins (Growth Factors)
IBA
06/2002
Therapy/Procedure
1
Therapeutics
08/2021